These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2104765)

  • 21. A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma.
    Regnault V; Rivat C; Vallet JP; Francois-Gerard C; Brochier G; Allain JP
    Thromb Res; 1987 Jan; 45(1):51-7. PubMed ID: 3105113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.
    Fijnvandraat K; Turenhout EA; van den Brink EN; ten Cate JW; van Mourik JA; Peters M; Voorberg J
    Blood; 1997 Jun; 89(12):4371-7. PubMed ID: 9192760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients.
    Scandella DH
    Semin Thromb Hemost; 2000; 26(2):137-42. PubMed ID: 10919405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Feb; 45(1):60-4. PubMed ID: 6787728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
    Wootla B; Dasgupta S; Mallet V; Kazatchkine MD; Nagaraja V; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):229-34. PubMed ID: 16651863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
    Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
    Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.
    Jacquemin MG; Desqueper BG; Benhida A; Vander Elst L; Hoylaerts MF; Bakkus M; Thielemans K; Arnout J; Peerlinck K; Gilles JG; Vermylen J; Saint-Remy JM
    Blood; 1998 Jul; 92(2):496-506. PubMed ID: 9657749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophilia in a Changing Treatment Landscape.
    Pelland-Marcotte MC; Carcao MD
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):409-423. PubMed ID: 31030810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complexes of IgG and plasma proteins in factor VIII preparations--a possible cause of adverse reactions.
    Wadsworth C; Blombäck M; Kjellman H; Hanson LA
    Vox Sang; 1985; 49(5):319-22. PubMed ID: 3936277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of human monocyte functions by factor VIII-anti-factor VIII complexes present in an affinity-purified factor VIII product.
    Mannhalter JW; Ahmad R; Eibl MM; Leibl H
    Blood; 1990 Feb; 75(3):810-1. PubMed ID: 2105110
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.
    Croissant MP; Zuzel M; Allain JP
    Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human alloantibody interferes with binding of factor IXa to the factor VIII light chain.
    Fijnvandraat K; Celie PH; Turenhout EA; ten Cate JW; van Mourik JA; Mertens K; Peters M; Voorberg J
    Blood; 1998 Apr; 91(7):2347-52. PubMed ID: 9516133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group.
    Shima M; Sawamoto Y; Nakai H; Kamisue S; Murakami T; Morichika S; Tanaka I; Hayashi K; Yoshioka A
    Int J Hematol; 1995 Jul; 62(1):35-43. PubMed ID: 7670006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide.
    Vlot AJ; Wittebol S; Strengers PF; Turenhout EA; Voorberg J; van den Berg HM; Mauser-Bunschoten EP
    Br J Haematol; 2002 Apr; 117(1):136-40. PubMed ID: 11918545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Different proportions of factor VIII and factor VIII inhibitors in their antigen-antibody complexes].
    Hintz G; Schwerdtfeger R
    Blut; 1982 Dec; 45(6):395-406. PubMed ID: 6814555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice.
    Ye P; Thompson AR; Sarkar R; Shen Z; Lillicrap DP; Kaufman RJ; Ochs HD; Rawlings DJ; Miao CH
    Mol Ther; 2004 Jul; 10(1):117-26. PubMed ID: 15233948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemical characterization of factor VIII inhibitors.
    Hoyer LW; Gawryl MS; de la Fuente B
    Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.